Form 4: Amedisys Inc. Executive Nick Muscato Reports Stock Transactions
SEC Form 4 Filing
Nick Muscato, Chief Strategy Officer of Amedisys Inc., reports the disposition of shares to cover tax obligations related to vested stock.
Summary
- On February 20, 2025, Nick Muscato, Chief Strategy Officer of Amedisys Inc., reported a transaction involving the disposition of 292 shares of common stock at a price of $91.09 per share to cover tax obligations.
- Following the transaction, Muscato directly owns 35,718 shares of Amedisys Inc.
- Muscato also indirectly owns 212 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This is a routine disclosure related to executive stock transactions, common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine executive stock transaction.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of the plan statement used for the report. |
| 02/20/2025 | Date of the stock transaction (disposition of shares). |
| 02/24/2025 | Date of signature for the report. |
Keywords
Amedisys Inc, Nick Muscato, Form 4, Stock Transaction, Beneficial Ownership, Chief Strategy Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.